Insulin glargine biosimilar (Basaglar) for the treatment of type 1 and type 2 diabetes mellitus
Agency for Care Effectiveness (ACE)
Record ID 32018002519
English
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/details/insulin-glargine-biosimilar-(basaglar)-for-the-treatment-of-type-1-and-type-2-diabetes-mellitus
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Insulin Glargine
- Hypoglycemic Agents
- Biosimilar Pharmaceuticals
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.